Evaluation of the M*Adhere Standard for Patient Efficacy and Health Economics System (M*Adhere SPEHEC® ) in Pharmaceutical Management

Chikako Ishimura; Mika Aohara; Tohru Sakamoto; Yuichi Furuya; Kenji Furuya; Aya Furukawa; Kaori Kadoyama; Toshiaki Nakamura

Return

Evaluation of the MAdhere Standard for Patient Efficacy and Health Economics System (MAdhere SPEHEC® ) in Pharmaceutical Management

VernacularTitle:薬学的管理における副作用管理支援システム（マディア・スピーク® ）の有用性評価
Author: Chikako ISHIMURA ¹ ; Mika AOHARA ¹ ; Tohru SAKAMOTO ¹ ; Yuichi FURUYA ¹ ; Kenji FURUYA ¹ ; Aya FURUKAWA ² ; Kaori KADOYAMA ³ ; Toshiaki NAKAMURA ³
Author Information

1. Horon Co., Ltd.
2. M* Adhere Inc.
3. Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences
Keywords: adverse event; pharmaceutical management; medication guidance; early detection; electronic medication record system
From:Japanese Journal of Drug Informatics 2020;22(2):108-115
CountryJapan
Language:Japanese
Abstract: Objective: In order to increase the efficiency and effectiveness of pharmacotherapy and maximize the benefit/risk ratio, patient follow-up after medication is imperative. Such follow-up includes medical adherence, drug efficacy, early detection and treatment of adverse events. All pharmacy pharmacists should, at their service counter, select and correctly identify the most noticeable symptoms of adverse drug reactions for the patient, especially with their other roles and responsibilities. Thus, we evaluated the usefulness of M*Adhere SPEHEC® in pharmaceutical management.Methods: During the month of April 2019, 21 pharmacists at six pharmacies responded to the survey.Results: Of 21 pharmacists, 18 (85.7%) stated that the efficiency and/or quality of pharmacotherapy management had improved. The system enabled evidence-based identification of drug adverse event symptoms, and the time for pharmaceutical care was reduced by an average of 2 min.Conclusion: Based on these results, M*Adhere SPEHEC® was confirmed to be highly useful in improving the efficiency and quality of pharmaceutical management for patient follow-up.